Release Date: 28/04/21 08:58 Summary: Quarterly Activities & Cashflow Report Price Sensitive: Yes Download Document 2.39MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%